Skip to playerSkip to main content
After-the-fact Expert
Zimmer Biomet shares surged 13.5% alongside an increase to the company’s full-year outlook. Quarterly net sales reached $2.063 billion, rising 3.1% on a reported basis and 3.7% in constant currency, while adjusted EPS came in at $1.90. Strength in hips and technology helped offset weaker knees, and CEO Ivan Tornos did not characterize the knee performance as part of a broader market slowdown.

For informational and educational purposes only. Not financial advice.

#ZimmerBiomet #ZBH #HealthcareStocks #Earnings

Category

🗞
News
Transcript
00:00Zimmer Biomit surged 13.48% today, alongside raised guidance.
00:06Zimmer Biomit makes orthopedic implants and surgical technology used by hospitals and surgeons for joint replacement procedures, especially knees and
00:16hips.
00:17The company's SEC filing reported net sales of $2.063 billion, up 3.1%, with adjusted earnings of $1.90
00:29per share.
00:30It also raised its full-year organic constant currency sales growth and adjusted earnings guidance.
00:37Yahoo said strength in hips and technology offset weakness in knees.
00:42The results coincided with the rally, though the sources didn't explicitly attribute the share move to them.
00:49Healthcare rose 3.08% today, so this went much further than the sector did.
00:56More on ZBH, full recap linked.

Recommended